Jeffrey Kindler

Pfizer (NYSE: PFE) CEO Jeffrey Kindler has unexpectedly announced his retirement after 4.5 years at the helm of the largest U.S. pharmaceuticals firm. Ian Read will takeover for the 55-year old for Kindler. Kindler oversaw Pfizer's massive $68 billion takeover of Wyeth. Pfizer also reported...

The Pfizer (NYSE: PFE) CEO, Jeffrey B. Kindler, speaking to analysts at Goldman Sachs (NYSE: GS) has stated that the chances of it entering into another large acquisition are unlikely. Pfizer’s integration with Wyeth is proceeding smoothly. Pfizer does not seek to divest its nutritionals/consumer...